Profound Medical Q2 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $2.233M Beat $2.100M Estimate
Benzinga Newsdesk 2 years ago
EarningsEarnings BeatsNews
Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.30) by 6.67 percent. This is a 20 percent increase over losses of $(0.35) per share from the
Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.30) by 6.67 percent. This is a 20 percent increase over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $2.233 million which beat the analyst consensus estimate of $2.100 million by 6.33 percent. This is a 39.39 percent increase over sales of $1.602 million the same period last year.